Cargando…

Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review

Coronavirus disease 2019 (COVID-19) is an emergent infectious pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is highly contagious and pathogenic. COVID-19 has rapidly swept across the world since it was first discovered in December 2019 and has drawn signific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zhi-Hua, Wang, Bin, Ma, Qian, Wang, Lin, Lin, Ya-Xin, Yan, Hai-Feng, Fan, Zi-Xuan, Chen, Hao-Jia, Ge, Zhao, Zhu, Feng, Wang, Hui-Jie, Zhang, Bao-Nan, Sun, Hai-Dong, Feng, Li-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320351/ https://www.ncbi.nlm.nih.gov/pubmed/34335247 http://dx.doi.org/10.3389/fphar.2021.668407

Ejemplares similares

Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
por: Yang, Zhi-Hua, et al.
Publicado: (2021)

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China
por: Zhuang, Wei, et al.
Publicado: (2020)

A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
por: Zhang, Nan, et al.
Publicado: (2020)

Adjuvant effects of Chinese medicinal tonics on gastric, liver, and colorectal cancers—OMICs-based contributions to understanding their mechanism of action
por: Zuo, Zhigang, et al.
Publicado: (2022)

Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model
por: Ge, Fei-lin, et al.
Publicado: (2021)

Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study
por: Wang, Li, et al.
Publicado: (2021)

Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis
por: Duan, Nai-fan, et al.
Publicado: (2021)

The Mechanisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Parkinson's Disease
por: Li, Xiaoliang, et al.
Publicado: (2017)

A specific SNP-based multiplex PCR assay for the simultaneous identification of two biological ingredients for the Chinese patent medicine, Danggui Buxue pill
por: Liu, Yinrong, et al.
Publicado: (2023)

Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms
por: Wang, Yunlai, et al.
Publicado: (2022)

Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms
por: Yang, Zhihua, et al.
Publicado: (2023)

Predictors of Polypharmacy Among Elderly Patients in China: The Role of Decision Involvement, Depression, and Taking Chinese Medicine Behavior
por: Chen, Chaoyi, et al.
Publicado: (2021)

Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines
por: Wu, Ying, et al.
Publicado: (2021)

Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery
por: Zhang, Wenjuan, et al.
Publicado: (2019)

The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: A systematic review and network meta-analysis of 179 trials
por: Huang, Peiying, et al.
Publicado: (2022)

TaqMan Probe-Based Quantitative Real-Time PCR to Detect Panax notoginseng in Traditional Chinese Patent Medicines
por: Lou, Qian, et al.
Publicado: (2022)

Efficacy and safety of combined Chinese and Western medicine in the treatment of knee osteoarthritis: a prospective, multicenter cohort study
por: Ye, Qian-Yun, et al.
Publicado: (2023)

Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines
por: Liu, Suyan, et al.
Publicado: (2021)

Mitochondrial toxicity evaluation of traditional Chinese medicine injections with a dual in vitro approach
por: Shen, Yunfu, et al.
Publicado: (2022)

Expert Consensus on the Treatment of Hypertension with Chinese Patent Medicines
por: Wang, Li Ying, et al.
Publicado: (2013)

An Overview of Systematic Reviews of Chinese Herbal Medicine for Parkinson's Disease
por: Jin, Xin-Chun, et al.
Publicado: (2019)

Untargeted Safety Pharmacology Screen of Blood-Activating and Stasis-Removing Patent Chinese Herbal Medicines Identified Nonherbal Ingredients as a Cause of Organ Damage in Experimental Models
por: Liu, Xinyan, et al.
Publicado: (2019)

Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis
por: Liu, Xiao-Yuan, et al.
Publicado: (2022)

An Efficacy and Feasibility Analysis of Chinese Patent Medicine Combined With Letrozole in the Treatment of Women With Ovulation Disorders: A Network Meta-Analysis
por: Zhu, Jing-Yan, et al.
Publicado: (2021)

Treatment options of traditional Chinese patent medicines for dyslipidemia in patients with prediabetes: A systematic review and network meta-analysis
por: Jiang, Li, et al.
Publicado: (2022)

The Bone-Protecting Efficiency of Chinese Medicines Compared With Western Medicines in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Comparative Studies
por: Cai, Xiao, et al.
Publicado: (2018)

Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19
por: Zheng, Shihao, et al.
Publicado: (2022)

Essential role of microglia in the fast antidepressant action of ketamine and hypidone hydrochloride (YL-0919)
por: Chang, Hai-Xia, et al.
Publicado: (2023)

Efficacy and Safety of Chinese Patent Medicine for the Prevention and Treatment of Radiotherapy and Chemotherapy-Induced Oral Mucositis: A Systematic Review and Meta-Analysis
por: Xie, Yufei, et al.
Publicado: (2022)

Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2022)

Traditional chinese medicine in coronary microvascular disease
por: Yang, Zhihua, et al.
Publicado: (2022)

Corrigendum: Essential role of microglia in the fast antidepressant action of ketamine and hypidone hydrochloride (YL-0919)
por: Chang, Hai-Xia, et al.
Publicado: (2023)

Sulfur Fumigation Processing of Traditional Chinese Medicinal Herbs: Beneficial or Detrimental?
por: Kan, Winnie Lai Ting, et al.
Publicado: (2011)

Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction
por: Wang, Yu, et al.
Publicado: (2022)

Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis
por: Bi, Yufei, et al.
Publicado: (2023)

Interaction Between Chinese Medicine and Warfarin: Clinical and Research Update
por: Zhuang, Wei, et al.
Publicado: (2021)

Erratum: A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
por: Frontiers Production Office,
Publicado: (2021)

Comparative efficacy of Chinese patent medicines for non-alcoholic fatty liver disease: A network meta-analysis
por: Zhang, Lihui, et al.
Publicado: (2023)

Observation of Voriconazole in the Treatment of Liver Failure Complicated With Invasive Pulmonary Fungal Infection Induced by Chinese Patent Medicine in Teenagers: 2 Case Reports
por: Su, Qian, et al.
Publicado: (2022)

Prominent Effects of Berbamine Hydrochloride on Alzheimer’s Disease Model Mice
por: Chen, Chang-lan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m8jifnkd7o5ce0hi7h82b065q4